MedPath

Role of whole body C11-PiB in patients with systemic amyloidosis: a pilot study

Phase 2
Recruiting
Conditions
amyloidose (eiwitstapelingen) in diverse organen en weefsels
amyloidosis
protein deposit
Registration Number
NL-OMON34619
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Patients known with systemic amyloidosis with known amyloid deposits in various organs

Exclusion Criteria

Patients < 18 years, pregnant or lactating women, and patients with claustrophobia

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Uptake of 11C-PiB in organs known with amyloid depositions.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable.</p><br>
© Copyright 2025. All Rights Reserved by MedPath